Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of CAIV-T (FluMist) in Healthy Children and Adolescents
NCT00192179Phase 2Completed
- Sponsor
- MedImmune
- Start
- Jun 2003
- Primary completion
- Jul 2003
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of live attenuated influenza vaccine in influenza, sponsored by MedImmune. Started Jun 2003; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192179.